NCT04234048 2025-09-22Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin LymphomaSciTech Development, Inc.Phase 1 Recruiting46 enrolled
NCT03493451 2024-10-26Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell NeoplasmsBeiGenePhase 2 Completed77 enrolled 20 charts
NCT00293488 2016-06-23SL-11047 in Treating Patients With Relapsed or Refractory LymphomaProgen PharmaceuticalsPhase 1 Completed20 enrolled
NCT01748721 2016-01-08MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaMorphotekPhase 1 Completed27 enrolled
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts